Goprolean

FEP Blue Wegovy and Zepbound Coverage in 2026, and the 2027 FEHB Change

FEHB, PSHB and FEP Blue · checked 8 November 2026

Short answer for 2026: on FEP Blue Standard and Basic, Wegovy is Tier 3 with prior approval. Zepbound is excluded on Standard and needs an approved formulary exception. On FEP Blue Focus, Wegovy isn't covered without an exception.

For 2027, OPM requires every FEHB and PSHB plan to cover at least one GLP-1 for weight loss, with intensive behavioral therapy. Open Season runs 9 November to 14 December 2026.

Checked against fepblue.org and OPM documents on 8 November 2026. Rules change; confirm with your plan.
Government employees: see your price with 10% off ↓

FEP Blue in 2026

  • Wegovy and Saxenda: Tier 3 with prior approval on Standard and Basic; not covered on Focus. FEP Blue's pharmacy FAQ says an approved exception puts Wegovy at Tier 2 on Focus.
  • Zepbound: on Standard's excluded-drug list. With an approved formulary exception it's Tier 3 on Standard and Basic and Tier 2 on Focus. An exception doesn't lower your cost-sharing.
  • Prior approval criteria: age 18 or over with a BMI of 30 or more, or 27 or more with heart disease or a weight-related condition, plus enrollment in a comprehensive weight-management program. The first approval lasts 6 months; renewal needs at least 5% weight loss kept off. For Zepbound, FEP Blue also requires that two oral weight-loss drugs haven't worked, plus a trial of preferred products.

What changes in 2027

OPM's Carrier Letter 2026-07 requires every FEHB plan and every Postal Service Health Benefits (PSHB) plan to cover at least one GLP-1 for weight loss and two oral anti-obesity drugs in 2027. Members must have documented intensive behavioral therapy before and during treatment, with 12 to 22 sessions a year and human coaching; app-only or AI-only programs don't count. FEP Blue hadn't published 2027 GLP-1 tiers on its What's New page when we checked, so read each plan's 2027 drug list during Open Season.

Federal retirees on FEP's Medicare drug plan have employer-group Part D coverage, which CMS includes in the Medicare GLP-1 Bridge.

A cash option for government employees

If your plan won't cover it, you don't meet the criteria, or you're waiting for 2027, Goprolean offers compounded semaglutide and tirzepatide as a cash-pay service. They're prescribed only if a licensed physician decides treatment is appropriate after reviewing your intake. Compounded medications are not FDA-approved and are not Wegovy or Zepbound. Goprolean doesn't bill FEHB or PSHB plans.

Federal, state and local government employees can verify with VerifyPass for 10% off their first order and every refill.

Government employees: 10% off every order
Verify in a couple of minutes with VerifyPass, an independent verification service. Your code appears on screen and we email it to you. Here's what you'll pay with it:
Most popular
3 months
$119.70/mo
$399 $359.10 with your code · save $39.90
Choose 3 months →
6 months
$107.10/mo
$714 $642.60 with your code · save $71.40
Choose 6 months →
Lowest per month
12 months
$89.10/mo
$1,188 $1,069.20 with your code · save $118.80
Choose 12 months →
Most popular
3 months
$176.70/mo
$589 $530.10 with your code · save $58.90
Choose 3 months →
6 months
$161.10/mo
$1,074 $966.60 with your code · save $107.40
Choose 6 months →
Lowest per month
12 months
$134.10/mo
$1,788 $1,609.20 with your code · save $178.80
Choose 12 months →
Prefer month to month? With your code it's $171.90 a month for semaglutide or $215.10 for tirzepatide.
Your code works on every Goprolean treatment, not only weight loss:
Testosterone (TRT)EnclomipheneSermorelinNAD+GlutathioneVitamin B12MetforminHair lossED treatment
Already have your code? Choose your plan above and enter it at checkout.
VerifyPass checks eligibility; Goprolean never sees your documents. By verifying you agree to receive your code and occasional offers by email. Unsubscribe anytime.
Compounded medications, prescribed only if a licensed physician decides treatment is appropriate. Prices checked on goprolean.com on 8 November 2026 and may change; the price at checkout is the price you pay. Labs and provider consultations are included, with no consultation or membership fee. Nothing renews automatically: request each refill in your member portal and your 10% applies again. Pay over time with Klarna, subject to approval.

See compounded semaglutide and compounded tirzepatide for full details, safety information and plans.

Common questions

Does FEP Blue cover Wegovy in 2026?
On FEP Blue Standard and Basic, Wegovy is Tier 3 with prior approval. It isn't covered on FEP Blue Focus unless a formulary exception is approved.
Does FEP Blue cover Zepbound?
Zepbound is on FEP Blue Standard's excluded-drug list. With an approved formulary exception it's Tier 3 on Standard and Basic and Tier 2 on Focus, and FEP Blue's criteria also require trying two oral weight-loss medications first.
What changes for FEHB in 2027?
OPM requires every FEHB and Postal Service (PSHB) plan to cover at least one GLP-1 for weight loss and two oral anti-obesity drugs in 2027, with documented intensive behavioral therapy before and during treatment. Check each plan's 2027 drug list during Open Season, 9 November to 14 December 2026.
Does Goprolean bill FEHB?
No. Goprolean is cash-pay and doesn't bill any FEHB or PSHB plan. Federal, state and local government employees can verify for 10% off Goprolean's own prices.
Sources (checked 8 November 2026): FEP Blue 2026 drug list; FEP Blue pharmacy FAQ; FEP Blue policy 5.99.030 (Wegovy); FEP Blue policy 5.99.031 (Zepbound); OPM Carrier Letter 2026-07.

Related

Cash-pay service. Goprolean is a cash-pay service. We don't bill Medicare, Medicaid, TRICARE, the VA, the Federal Employees Health Benefits Program or any insurer, and nothing you buy here is submitted to a government health program. The verified-community discount is a cash discount on Goprolean's own prices. It isn't insurance and can't be combined with other offers.

No affiliation. Goprolean isn't affiliated with or endorsed by Medicare/CMS, the Department of Defense, TRICARE, the Department of Veterans Affairs, OPM, any employer or any health plan. Eligibility is verified by VerifyPass.

Coverage information is general, was checked on 8 November 2026, and plans change. Ask your plan about your own coverage.

Compounded medications. Compounded semaglutide and tirzepatide are prepared by a licensed pharmacy for an individual patient. They are not FDA-approved, have not been reviewed by the FDA for safety or effectiveness, and are not Wegovy®, Ozempic®, Zepbound® or Mounjaro®. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk; Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Goprolean isn't affiliated with either company.

Physician review. Prescriptions are issued only after a medical intake is reviewed by a licensed physician, who may determine that treatment is not appropriate, in which case the order is cancelled and you're refunded in full. Individual results vary. Pay over time with Klarna, subject to approval.

Goprolean is the telehealth and pharmacy service of Prolean Wellness, Scottsdale, Arizona. Is Goprolean legitimate? · How we handle health information · Privacy · Terms